Related Pages for SBILIFE
SBILIFE
Sbi Life Insurance Co LtdNo results found.
Related News - SBILIFE
SBI Life Insurance: Nuvama on SBI Life Insurance Buy with Target Price ₹2,390 as muted Q4 with weak 5.5% APE growth (dragged by group APE -13.8% and VNB miss), but improving product mix (PAR traction), strong annuity/protection growth, FY26 VNB +12.2%, and guided FY27 outlook of ~14% APE growth with 27–28% margins support recovery.
23 Apr 2026 08:58 AM
SBI Life Insurance: Nuvama on SBI Life Insurance Buy with Target Price ₹2,390 as muted Q4 with weak 5.5% APE growth (dragged by group APE -13.8% and VNB miss), but improving product mix (PAR traction), strong annuity/protection growth, FY26 VNB +12.2%, and guided FY27 outlook of ~14% APE growth with 27–28% margins support recovery.
SBI Life Insurance: HDFC Securities on SBI Life Insurance Buy with Target Price ₹2,400 as APE/VNB growth of 13%/14% YoY slightly missed, margins impacted by ~150bps GST ITC but supported by higher non-PAR mix, strong ~20% ROEV, shift away from ULIP to higher-margin products, strong SBI distribution moat, and ~14–15% CAGR growth outlook underpin valuation at 2.1x Mar-28E EV.
23 Apr 2026 08:58 AM
SBI Life Insurance: HDFC Securities on SBI Life Insurance Buy with Target Price ₹2,400 as APE/VNB growth of 13%/14% YoY slightly missed, margins impacted by ~150bps GST ITC but supported by higher non-PAR mix, strong ~20% ROEV, shift away from ULIP to higher-margin products, strong SBI distribution moat, and ~14–15% CAGR growth outlook underpin valuation at 2.1x Mar-28E EV.
SBI Life Insurance: HSBC on SBI Life Insurance Buy with Target Price ₹2,270 as 4QFY26 margin impacted by slower APE growth and GST reforms, but strong non-SBIN channel growth, expansion in new non-linked products, and higher-than-industry APE growth potential support ~18% EV CAGR (FY26–29) and long-term compounding.
23 Apr 2026 08:57 AM
SBI Life Insurance: HSBC on SBI Life Insurance Buy with Target Price ₹2,270 as 4QFY26 margin impacted by slower APE growth and GST reforms, but strong non-SBIN channel growth, expansion in new non-linked products, and higher-than-industry APE growth potential support ~18% EV CAGR (FY26–29) and long-term compounding.
